Cardiac AI: Why Clinical Validation Precedes Pilot Investment
Evaluating a new cardiac AI vendor has to start with clinical validation, because without it, you’re just buying…
Evaluating a new cardiac AI vendor has to start with clinical validation, because without it, you’re just buying…
When a credential-stuffing attack blew the doors off consumer genomic data at 23andMe, privacy stopped being a line…
The Theranos story gets a lot clearer when you look at it through the lens of regulatory compliance.…
If you can’t see clear, understandable results for all your patient populations, you don’t have an equitable cardiac…
Automation in health systems ran ahead of its evidence. The recorded cases show the money raised, the valuation,…
When you’re evaluating cardiac AI tools, clinical validation is the single most important pre-purchase step. It’s how you…
When you’re evaluating AI health tools, you have to separate verifiable claims from pure marketing assertions. For health…
When a health system rolls out a new cardiac program, its outcomes have to be legible and consistent…
An FDA clearance is the first credibility check for any AI health product, but it’s just a foot…
An FDA-cleared algorithm is just the beginning. It still needs strong integration safety protocols for what happens when…